Royalty Pharma Sub-Manager, LLC historic quarter change: Foreign Other Stocks, New
In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), over 2 quarters from 2025-12-31 to 2026-06-30, Royalty Pharma Sub-Manager, LLC opened 0 positions, added to 0, reduced 0 and sold out of 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 2081668), 2 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-21); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-08-21). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2025-12-31.
No position of this class changed this way in the filings compared.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Marest Capital, LLC | United States | $0.173B | 29 |
| Dynamic Wealth Strategies, LLC | United States | $0.173B | 288 |
| Kurv Investment Management LLC | United States | $0.173B | 62 |
| Capital Today Evergreen Fund, L.P. | Cayman Islands | $0.173B | 3 |
| PETERSON WEALTH MANAGEMENT | United States | $0.172B | 166 |
| Godshalk Welsh Capital Management, Inc. | United States | $0.172B | 129 |
| Forbes Financial Planning, Inc. | United States | $0.173B | 38 |
| Innovative Asset Advisors Group, LLC | United States | $0.173B | 1,040 |
| Saxony Capital Management, LLC | United States | $0.172B | 161 |
| Tiptree Advisors, LLC | United States | $0.172B | 22 |